Soft Tissue Sarcoma: From Diagnosis to Prognosis
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 396
Special Issue Editor
2. Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
Interests: gastrointestinal/biliary diseases; metabolic diseases; congenital heart disease; mitochondrial DNA-related cardiomyopathies; carcinogenesis (bone/liver)
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The diagnosis of a mesenchymal malignancy or sarcoma requires an arsenal of medical tools, including X-rays, computed tomography (CT) scans, magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. However, the diagnosis or confirmation of a sarcoma still requires the involvement of one or more pathologists. The number of entities ranging from benign to malignant has increased enormously in the last few decades, and the current IARC/WHO classification lists dozens of categories. Recognized for their exceptional service to patients, hospitals, health insurance behemoths, and major corporations, the consultant histopathologists and databases of the Children’s Oncology Group (COG) and the International Society of Pediatric Oncology (SIOP) stand at the forefront of the advancements of pediatric and adult oncology. They pinpoint morphological aspects that have helped molecular biologists identify several pathways that may be targeted for therapy in precision medicine. All physicians involved in diagnosing sarcomas are vital to maintaining operational safety in healthcare and regulatory compliance with significant healthcare agencies. This Special Issue delves into the complexities of soft tissue sarcoma, exploring the journey from diagnosis to prognosis.
Through a compilation of expert insights and cutting-edge research, this Special Issue aims to deepen understanding, discuss best practices, and shed light on the latest advancements in this tumor's diagnosis, treatment, and prognosis. It is an invaluable resource for clinicians, researchers, and patients, fostering a shared commitment to conquer this elusive disease.
Prof. Dr. Consolato M. Sergi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- soft tissue
- mesenchyme
- bone
- pathogenesis
- miRNA
- imaging
- diagnosis
- therapy
